期刊文献+

曲安奈德染色法在玻璃体切除手术中的应用 被引量:1

Triamcinolone acetonide in vitreous surgery
下载PDF
导出
摘要 目的探讨曲安奈德(TA)染色法在玻璃体切除手术中协助辨别和清除残留玻璃体皮质和视网膜前膜的作用及效果。方法选取2008年6月至2010年5月,对我院85例(88只眼)玻璃体视网膜疾病行TA染色法玻璃体切除手术,切除中轴部玻璃体后,注入TA悬浊液染色玻璃体皮质和增生膜,切除残留的玻璃体皮质和视网膜前膜。术后随访时重点观察患者视力、眼压、白内障形成、玻璃体残留及视网膜复位情况。结果 85例(88只眼)术中注入TA后,残留的玻璃体皮质及视网膜前膜均能清晰地显示,容易辨认切除残留的玻璃体皮质和视网膜前膜位置和范围。术后随访观察6~12个月,81只眼(92.05%)视力有不同程度的提高,与手术前相比差异具有统计学意义(P<0.05)。术前40只眼视网膜脱离术后38只眼(95%)视网膜完全复位,术后未发现与TA相关的严重并发症。结论玻璃体切除手术中,应用TA染色玻璃体,可以清晰地显示残留的玻璃体皮质和视网膜前膜,有助于彻底切除玻璃体皮质和视网膜前膜,提高了手术的安全性和准确性。 Objective To discuss the role and effect of the Triamcinolone acetonide(TA) injection applied in vitreoretinal surgery for assisting to distinguish and remove residual vitreous cortex and epiretinal membrane.Methods After excision of the axial vitreous in 85 cases(88 eyes) of vitreoretinal diseases,TA was used to dye the vitreous and then vitrectomy technique was used to remove the residual vitreous and epiretinal membrane.During the follow-up,visual acuity,intraocular pressure,lens opacity,condition of the residual vitreous and the rate of retina reattachment were recorded.Results The residual vitreous and epiretinal membrane can be easily identified and removed with TA and vitrectomy technique.The location and coverage of the residual vitreous cortex and epiretinal membrane were clearly shown by TA dyeing.The visual acuity in 81 eyes(92.05%) was increased and retina was reattached in 38 eyes(95%) eyes after 6 to 12 months.there was a significant difference of preoperative and postoperative vision(P〈0.05).Conclusion Residual vitreous cortex and epiretinal membrane can be easily identified and removed with TA dyeing and vitrectomy technique.The procedures were performed easily,surely and safely.
出处 《临床眼科杂志》 2012年第2期117-120,共4页 Journal of Clinical Ophthalmology
关键词 曲安奈德 染色玻璃体切除手术 玻璃体视网膜疾病 Triamcinolone acetonide Chromovitrectomy Vitreoretinal diseas
  • 相关文献

参考文献13

二级参考文献77

  • 1冷云霞,李松峰,张少冲.曲安奈德在难治性黄斑水肿中的应用[J].国外医学(眼科学分册),2004,28(5):330-333. 被引量:11
  • 2陈长征,邢怡桥.曲安奈德在玻璃体切割术中的辅助应用[J].国外医学(眼科学分册),2004,28(6):387-390. 被引量:17
  • 3王凯,姜燕荣,黎晓新.曲安奈德玻璃体内注射对视网膜的影响[J].中华眼底病杂志,2005,21(4):229-232. 被引量:9
  • 4刘武,王景昭.玻璃体内注射曲安奈德的问题与并发症[J].中华眼底病杂志,2005,21(4):267-270. 被引量:39
  • 5孟浩,惠延年.染色玻璃体切除术[J].国外医学(眼科学分册),2005,29(5):289-292. 被引量:6
  • 6Danis RP,Cinlla TA,Pratt LA,et al.lntravitreal triamcinolone acetonide in exudative age-related macular degeneration.Retina,2000, 20: 244-250.
  • 7Ip MS,Kumar KS.Intravitreous triamcinolone acetonide as treatment for macular edema from central retinal vein occlusion.Arch Ophthalmol,2002,120:1217-1219.
  • 8Jonas JB, Hayler JK, Sofker A, et al.Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy. Am J Ophthalmol, 2001,131 : 468-471.
  • 9Sakamoto T,Miyazaki M,Hisatomi T,et al.Triameinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative.blood-ocular barrier breakdown.Graefes Arch Clin Exp Ophthalmol, 2002,240: 423-429.
  • 10Peyman GA, Cheema R, Conway MD, et al.Triamcinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloid during pars plana vitreetomy.Retina, 2000,20: 554-555.

共引文献55

同被引文献11

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部